Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2021-12-03 / Clin Cancer Res 2021 Dec;Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
/in Dendritic Cells, International Publications, Prostate Cancer /von 2021-11-11 / Prostate 2021 Nov;Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-11-03 / Diseases 2021 Nov;9(4)Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, NSCLC, SCLC /von 2021-11-02 / Cancers (Basel) 2021 Nov;13(21)Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
/in Curcuma, International Publications /von 2021-10-25 / Phytother Res 2021 Oct;Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2021-10-16 / Eur J Cancer 2021 Oct;158:123-132Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
/in Curcuma, International Publications /von 2021-10-14 / Biomedicines 2021 Oct;9(10)Curcuma as an adjuvant in colorectal cancer treatment
/in Colorectal Cancer, Curcuma, International Publications /von 2021-10-09 / Life Sci 2021 Dec;286:120043
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
- Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
- A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma